{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:27:42Z","timestamp":1768609662814,"version":"3.49.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["endocrinologydiabetes.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Endocrinology and Diabetes"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.aed.2025.05.002","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T04:08:06Z","timestamp":1747368486000},"page":"121-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Use of Radioactive Iodine in Type 2 Amiodarone-Induced Thyrotoxicosis"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3358-1460","authenticated-orcid":false,"given":"Sonia","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Run","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aed.2025.05.002_bib1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2147\/TCRM.S96606","article-title":"Dysfunction of the thyroid gland during amiodarone therapy: a study of 297 cases","volume":"12","author":"Czarnywojtek","year":"2016","journal-title":"Ther Clin Risk Manag"},{"issue":"10","key":"10.1016\/j.aed.2025.05.002_bib2","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.aed.2025.05.002_bib3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1210\/clinem\/dgaa686","article-title":"Evaluation and treatment of amiodarone-induced thyroid disorders","volume":"106","author":"Ylli","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.aed.2025.05.002_bib4","first-page":"716","article-title":"Radioactive iodine in the treatment of type-2 amiodarone-induced thyrotoxicosis","volume":"100","author":"Gursoy","year":"2008","journal-title":"J Natl Med Assoc"},{"issue":"2","key":"10.1016\/j.aed.2025.05.002_bib5","first-page":"209","article-title":"Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT)","volume":"30","author":"Czarnywojtek","year":"2009","journal-title":"Neuro Endocrinol Lett"},{"issue":"12","key":"10.1016\/j.aed.2025.05.002_bib6","doi-asserted-by":"crossref","first-page":"695","DOI":"10.20452\/pamw.2556","article-title":"Radioiodine therapy in patients with type II amiodarone-induced thyrotoxicosis","volume":"124","author":"Czarnywojtek","year":"2014","journal-title":"Pol Arch Med Wewn"},{"issue":"6","key":"10.1016\/j.aed.2025.05.002_bib7","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1210\/jc.2010-0180","article-title":"Approach to the patient with amiodarone-induced thyrotoxicosis","volume":"95","author":"Bogazzi","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.aed.2025.05.002_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000486957","article-title":"European thyroid association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction","volume":"7","author":"Bartalena","year":"2018","journal-title":"Eur Thyroid J"},{"issue":"2","key":"10.1016\/j.aed.2025.05.002_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.eupc.2003.11.002","article-title":"Radioiodine ablation of the thyroid to prevent recurrence of amiodarone-induced thyrotoxicosis in patients with resistant tachyarrhythmias","volume":"6","author":"Hermida","year":"2004","journal-title":"Europace"},{"issue":"4","key":"10.1016\/j.aed.2025.05.002_bib10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.5812\/ijem.5406","article-title":"Recombinant TSH and lithium overcomes amiodarone-induced low radioiodine uptake in a thyrotoxic female","volume":"10","author":"Laplano","year":"2012","journal-title":"Int J Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.aed.2025.05.002_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2265.2009.03600.x","article-title":"Recombinant human TSH as an adjuvant to radioiodine for the treatment of type 1 amiodarone-induced thyrotoxicosis: a cautionary note","volume":"72","author":"Bogazzi","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.aed.2025.05.002_bib12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5603\/EP.2014.0036","article-title":"Results of preventive radioiodine therapy in euthyroid patients with history of hyperthyroidism prior to administration of amiodarone with permanent atrial fibrillation - a preliminary study","volume":"65","author":"Czarnywojtek","year":"2014","journal-title":"Endokrynologia Polska"}],"container-title":["AACE Endocrinology and Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050915725000311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050915725000311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T13:16:30Z","timestamp":1768569390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050915725000311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S3050915725000311"],"URL":"https:\/\/doi.org\/10.1016\/j.aed.2025.05.002","relation":{},"ISSN":["3050-9157"],"issn-type":[{"value":"3050-9157","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Radioactive Iodine in Type 2 Amiodarone-Induced Thyrotoxicosis","name":"articletitle","label":"Article Title"},{"value":"AACE Endocrinology and Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aed.2025.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the AACE.","name":"copyright","label":"Copyright"}]}}